INS and metabolic dysfunction-associated steatotic liver disease: They underscored the significance of hepatocyte-derived sEVs as carriers of SFAs, driving liver inflammation and insulin resistance through a hepatocyte–macrophage crosstalk, which has implications for NAFLD-related lipotoxicity and consequently hepatocarcinogenesis [34].